ARCHIVES

FDA, NCI Seek Compromise On Survival Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

Step By Step: New Tenure Track, Appointments Process

August 5, 1994

Sunitinib May Be Associated With Cardiac Toxicity

January 25, 2008

Walter Curran Succeeds Brian Leyland-Jones As Director Of Emory’s Cancer Center

September 25, 2009

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research

May 14, 1993

A tissue bank to break the bank? NCI, National Dialogue on Cancer plan expensive resource.

August 8, 2003